Investigators from RCSI University of Medicine and Health Sciences have recently discovered that a high level of a critical protein that plays a role in blood clotting called the Willebrand Factor can cause worsening outcomes among breast cancer patients. These outcomes published in the Journal of Thrombosis and Haemostasis can help researchers better understand breast cancer and reduce life-threatening blood clots risk and spread of cancer among patients. Furthermore, using anticoagulants or blood thinners can inhibit the effect of the Willebrand Factor by lowering its level and preventing cancer cells spread in the blood. In conclusion, such findings help researchers understand the increased risk of blood clots among breast cancer patients, which might contribute to the worsening disease, the spread of cancer, and disease progression. By: Advances and More Medical Reporters Reference: Research identifies links between high levels of blood clotting proteins and poorer breast cancer outcomes - ecancer. (2022). Retrieved 26 July 2022, from https://ecancer.org/en/news/22018-research-identifies-links-between-high-levels-of-blood-clotting-proteins-and-poorer-breast-cancer-outcomes